Business Description
Enveric Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US02362F1049
Description
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 426.7 | |||||
| Equity-to-Asset | 0.37 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 59.6 | |||||
| 3-Year EPS without NRI Growth Rate | 73.4 | |||||
| 3-Year FCF Growth Rate | 62.4 | |||||
| 3-Year Book Growth Rate | -79.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.4 | |||||
| 9-Day RSI | 41.72 | |||||
| 14-Day RSI | 39.05 | |||||
| 6-1 Month Momentum % | -59.23 | |||||
| 12-1 Month Momentum % | -37.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.39 | |||||
| Quick Ratio | 1.39 | |||||
| Cash Ratio | 1.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -448.3 | |||||
| Shareholder Yield % | 1.87 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -204.29 | |||||
| ROA % | -136.47 | |||||
| ROIC % | -434.41 | |||||
| ROC (Joel Greenblatt) % | -2776.39 | |||||
| ROCE % | -149.3 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 26.91 | |||||
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| EV-to-EBIT | 0.19 | |||||
| EV-to-EBITDA | 0.19 | |||||
| EV-to-FCF | 0.23 | |||||
| Price-to-Net-Current-Asset-Value | 2.24 | |||||
| Price-to-Net-Cash | 42 | |||||
| Earnings Yield (Greenblatt) % | 526.32 | |||||
| FCF Yield % | -405.33 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ENVB
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enveric Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -11.54 | ||
| Beta | 0.66 | ||
| Volatility % | 155.81 | ||
| 14-Day RSI | 39.05 | ||
| 14-Day ATR ($) | 0.143825 | ||
| 20-Day SMA ($) | 1.574765 | ||
| 12-1 Month Momentum % | -37.8 | ||
| 52-Week Range ($) | 1.3 - 6.98 | ||
| Shares Outstanding (Mil) | 2.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enveric Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enveric Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enveric Biosciences Inc Frequently Asked Questions
What is Enveric Biosciences Inc(ENVB)'s stock price today?
The current price of ENVB is $1.68. The 52 week high of ENVB is $6.98 and 52 week low is $1.30.
When is next earnings date of Enveric Biosciences Inc(ENVB)?
The next earnings date of Enveric Biosciences Inc(ENVB) is .
Does Enveric Biosciences Inc(ENVB) pay dividends? If so, how much?
Enveric Biosciences Inc(ENVB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers